Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Locations section was expanded to include participating sites across multiple states under a consolidated listing, and older per-state subsections were removed with the revision updated to 3.3.3.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedEditorial notes were added to explain PubMed-derived publications and a revision label was updated; these changes do not modify the study's design, endpoints, eligibility criteria, or other core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe funding-status banner related to government operations was removed, and there are no changes to the study details or page navigation.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant content changes detected on the Study Details page for NCT03866174; the updates seem to be formatting and layout tweaks without edits to core study information like locations, criteria, dates, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a government funding notice and a new v3.2.0 revision; removed the old v3.1.0 revision.SummaryDifference2%

- Check100 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.